Revision of USP <831> Refractive Index
Recommendation

9-11 June 2026
Development, Validation & Control
In the current Pharmacopeial Forum, PF 47(3), a proposal of USP Chapter <831> Refractive Index has been published for comments.
The proposal is based on the version of the chapter official prior to 2013. According to the USP, the previous proposal in PF 46(4) has been canceled, and the text has been revised to address comments received.
Besides minor editorial changes to update the chapter to the current USP style, the revisions to the chapter include the following:
- Add specification for an apparatus that provides a means of operation at the prescribed temperature with readings to at least ±0.1°.
- Add operational qualification requirements for accuracy that state the measurement of a certified reference material should agree with the stated certified value within the limits of the expanded uncertainty of the reference material added to the performance specification of the instrument.
- Clarify the performance qualification requirements.
- Remove the three replicate measurements of the sample from the Measurement Procedure section that was previously proposed in PF 46(4).
The deadline for submitting comments is July 31, 2021.
The draft chapter USP <831> Refractive Index can be viewed here. (Please note: a one-time registration is required to access the Pharmacopeial Forum.)
Related GMP News
18.05.2026EMA updates Q&A on Reduced Testing of Incoming Starting Materials
18.05.2026China: NMPA publishes Draft Guidance on Inspection of Data Integrity in QC Laboratories
18.05.2026FDA Warning Letter to EU OTC Manufacturer
13.05.2026BP Publishes Key Insights on Chromatography and SST
06.05.2026Laboratory Controls in Focus in FDA Warning Letter to U.S. OTC Manufacturer
06.05.2026WHO Working Document on Bioequivalence open for Public Consultation


